Related Experiment Video
Updated: Sep 2, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Ganoderic acid D prevents oxidative stress-induced senescence by targeting 14-3-3ε to activate CaM/CaMKII/NRF2
Huan Yuan1,2, Yan Xu1,2, Yi Luo1,2
1Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Abstract:
Stem cell senescence is an important cause of aging. Delaying senescence may present a novel way to combat aging and age-associated diseases. This study provided a mechanistic insight into the protective effect of ganoderic acid D (GA-D) against human amniotic mesenchymal stem cell (hAMSCs) senescence. GA-D, a Ganoderma lucidum-derived triterpenoid, markedly prevented hAMSCs senescence via activating the Ca2+ calmodulin (CaM)/CaM-dependent protein kinase II (CaMKII)/nuclear erythroid 2-related factor 2 (Nrf2) axis, and 14-3-3ε was identified as a target of GA-D. 14-3-3ε-encoding gene (YWHAE) knockdown in hAMSCs reversed the activation of the CaM/CaMKII/Nrf2 signals to attenuate the GA-D anti-aging effect and increase senescence-associated β-galactosidase (SA-β-gal), p16 and p21 expression levels, including reactive oxygen species (ROS) production, thereby promoting cell cycle arrest and decreasing differentiation potential. YWHAE overexpression maintained or slightly enhanced the GA-D anti-aging effect. GA-D prevented d-galactose-caused aging in mice by significantly increasing the total antioxidant capacity, as well as superoxide dismutase and glutathione peroxidase activity, and reducing the formation of malondialdehyde, advanced glycation end products, and receptor of advanced glycation end products. Consistent with the protective mechanism of GA-D against hAMSCs senescence, GA-D delayed the senescence of bone-marrow mesenchymal stem cells in this aging model in vivo, reduced SA-β-gal and ROS production, alleviated cell cycle arrest, and enhanced cell viability and differentiation via regulating 14-3-3ε and CaM/CaMKII/Nrf2 axis. Therefore, GA-D retards hAMSCs senescence by targeting 14-3-3ε to activate the CaM/CaMKII/Nrf2 signaling pathway. Furthermore, the in vivo GA-D anti-aging effect may involve the regulation of stem cell senescence via the same signal axis.
Insights
Ganoderic acid D (GA-D) delays stem cell senescence, a key aging factor. This compound protects human amniotic mesenchymal stem cells by activating the CaM/CaMKII/Nrf2 pathway, offering a potential anti-aging strategy.
Area of Science:
- Cellular Biology
- Gerontology
- Molecular Medicine
Background:
- Stem cell senescence is a significant contributor to organismal aging and age-related diseases.
- Identifying compounds that can delay senescence is crucial for developing anti-aging interventions.
- Ganoderma lucidum-derived compounds, like ganoderic acid D (GA-D), show potential in modulating cellular processes.
Purpose of the Study:
- To elucidate the protective mechanism of ganoderic acid D (GA-D) against human amniotic mesenchymal stem cell (hAMSCs) senescence.
- To investigate the role of the Ca2+/calmodulin (CaM)/CaM-dependent protein kinase II (CaMKII)/nuclear erythroid 2-related factor 2 (Nrf2) signaling axis in GA-D's anti-aging effects.
- To evaluate the in vivo anti-aging efficacy of GA-D in a mouse model.
Main Methods:
- hAMSCs were treated with GA-D, and senescence markers (SA-β-gal, p16, p21) and reactive oxygen species (ROS) were assessed.
- Gene knockdown and overexpression of 14-3-3ε (YWHAE) were performed to confirm its role in GA-D's mechanism.
- An in vivo aging model in mice induced by d-galactose was used to evaluate GA-D's systemic anti-aging effects and its impact on stem cell function.
Main Results:
- GA-D significantly prevented hAMSCs senescence by activating the CaM/CaMKII/Nrf2 pathway, with 14-3-3ε identified as a direct target.
- Modulating 14-3-3ε expression reversed or enhanced GA-D's anti-senescence effects, confirming its critical role.
- In vivo, GA-D improved antioxidant capacity, reduced aging biomarkers, and delayed mesenchymal stem cell senescence in mice, mirroring the in vitro findings.
Conclusions:
- GA-D effectively retards hAMSCs senescence by targeting 14-3-3ε and activating the CaM/CaMKII/Nrf2 signaling pathway.
- The study provides a mechanistic understanding of GA-D's anti-aging properties at the cellular and organismal levels.
- GA-D represents a promising therapeutic candidate for combating aging and age-associated diseases by modulating stem cell senescence.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Mesenchymal Stem Cells
Nitric Oxide Signaling Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Tissue Renewal without Stem Cells
However, failure of such a system...
Replicative Cell Senescence